Amplification of purified prions in vitro
Methods in Molecular Biology, ISSN: 1064-3745, Vol: 459, Page: 117-130
2008
- 5Citations
- 21Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations5
- Citation Indexes5
- CrossRef5
- Captures21
- Readers21
- 21
Book Chapter Description
Summary: The infectious agents of prion diseases are unorthodox, and they seem to be composed primarily of a misfolded glycoprotein called the prion protein (PrP). Replication of prion infectivity is associated with the conversion of PrP from its normal, cellular form (PrP) into a pathogenic form (PrP), which is characterized biochemically by relative detergent insolubility and protease resistance. Several techniques have been developed in which PrP molecules can be converted into the PrP conformation in vitro (1-8). These biochemical techniques recapitulate several specific aspects of in vivo prion propagation (1-3), and one method, the protein misfolding cyclic amplification technique, also has been shown to amplify infectivity (5). In this chapter, we describe a method for amplifying PrP molecules from hamster prions in vitro using purified substrates. Specific protocols for substrate preparation, reaction mixture, and product detection are explained. Purified PrP amplification assays are currently being used to study the biochemical mechanism of prion formation. © 2008 Humana Press, a part of Springer Science + Business Media, LLC.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84934436978&origin=inward; http://dx.doi.org/10.1007/978-1-59745-234-2_9; http://www.ncbi.nlm.nih.gov/pubmed/18576152; http://link.springer.com/10.1007/978-1-59745-234-2_9; https://dx.doi.org/10.1007/978-1-59745-234-2_9; https://link.springer.com/protocol/10.1007/978-1-59745-234-2_9; http://www.springerlink.com/index/10.1007/978-1-59745-234-2_9; http://www.springerlink.com/index/pdf/10.1007/978-1-59745-234-2_9
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know